Institute of Psychiatry, De Crespigny Park, London SE5 8AF, tel: 020 7848 0139, e-mail: R.Gray{at}iop.kcl.ac.uk
Institute of Psychiatry, London
National Institute for Mental Health in England, London
R.G. and N.B. co-chair the National Institute for Mental Health in England (NIHME) mental health nurse prescribing group.
|
|
|---|
A postal questionnaire survey was conducted of the directors of nursing of all mental health NHS trusts in England, in order to examine current activities and attitudes regarding nurse supplementary prescribing (NSP) in psychiatric settings.
RESULTS
Fifty-four per cent of nurse directors returned the questionnaire. They perceived that NSP was an important means for improving patient care and treatment, particularly in community settings. In their opinion, psychiatrists were generally not opposed to its introduction. To date, relatively few mental health nurses have received training in NSP.
CLINICAL IMPLICATIONS
Directors of nursing have positive views and experiences of NSP. Widespread implementation of NSP is likely to occur over the next few years and psychiatrists will need to consider how this will impact on their role.
|
|
|---|
Nurse supplementary prescribing (NSP) was introduced in 2003 specifically for use in the management of chronic diseases such as asthma and diabetes, and in mental health, schizophrenia and dementia (Department of Health, 2003). Nurse supplementary prescribing is a voluntary partnership between an independent prescriber (the psychiatrist) and a supplementary prescriber (a suitably trained registered nurse), to implement an agreed patient-specific clinical management plan (CMP) that can include most medicines (Department of Health, 2003). The expected benefits of the introduction of NSP are:
If appropriate and indicated in the CMP, the supplementary nurse prescriber can adjust the dosages of medications, switch and stop medicines (Department of Health, 2003). Nurses are required to attend a 26-day university-based training programme, which is not mental health specific, and undergo a period of supervised practice with an experienced doctor in order that they may become a registered supplementary prescriber (Nursing and Midwifery Council, 2003).
Directors of nursing have a central role to play in the successful implementation of supplementary prescribing in England as it comes into practice. It is timely to map current practice within mental health services, NHS trust preparation, and explore nurse directors views and experiences of supplementary prescribing.
|
|
|---|
Data collection and analysis
We wrote to the directors of nursing in the 83 NHS mental health trusts in
England explaining the aims and purpose of the survey and inviting them to
participate. The questionnaire was sent out in March 2004, and again in June
2004 to those directors who had not responded.
|
|
|---|
Sample characteristics
The catchment areas served by the NHS trusts who responded were as follows:
18% urban; 13% rural; 18% suburban; 44% mixed; 7% regional and national. The
trusts served a total population of 31 million (approximately 63% of the
population of England). The 45 directors who responded employed a total of 26
306 qualified mental health nurses, a mean of 584 per trust.
Number of nurse prescribers
In the trusts surveyed, a total of 102 nurses had completed
nurse-prescribing training; an average of two per trust. The majority
(n=83, 81%) of qualified mental health nurse prescribers worked in
four trusts. A further 128 mental health nurses were currently undertaking
training. The majority of trusts (n=28, 62%), at the time of the
survey, had no mental health nurses who had completed prescribing training or
who were undertaking a prescribing role (n=37, 82%).
Benefits and barriers
The majority of directors of nursing (n=30, 68%) saw NSP as a
very significant development for improving the experience of
care for service users, with half reporting that their trust had a strategy
for implementing nurse prescribing (n=21, 48%) and one-third seeing
the implementation of NSP as high priority for their trust (n=14,
32%). The directors reported the main potential benefits from NSP as
being:
Table 1 shows the service settings where nurse directors believed that NSP may have most potential benefit. Community-based services were those most frequently identified.
|
View this table: [in a new window] | Table 1. Where will supplementary prescribing be most useful? |
Training and accessibility of appropriate courses
In the 24 NHS trusts where nurses were training for or were currently
undertaking prescribing roles, half (n=12) reported that the feedback
they had received about prescribing training was generally positive. However,
only just under half (n=10, 42%) of respondents reported that they
felt confident that the prescribing training alone had adequately prepared
nurses to undertake a supplementary prescribing role. Directors reported that
additional medication management training (e.g.
Gray et al, 2004) either prior to or after completing prescribing training was required in 63%
(n=15) of trusts where nurses were training for or were currently
undertaking prescribing roles.
Medical supervision and support
The majority of the directors of nursing (n=29, 66%) who responded
to the survey indicated that they did not think that psychiatrists were
adequately prepared to mentor or supervise supplementary mental health nurse
prescribers.
Consultant psychiatrists
When directly asked about the attitudes of psychiatrists to NSP, only a
minority of directors (n=5, 12%) reported that, in their experience,
psychiatrists had a negative attitude. Most were seen as having a positive
(n=16, 37%) or neutral (n=19, 42%) attitude.
|
|
|---|
The barriers to the introduction of NSP identified by respondents do not appear to be insurmountable. Concerns about the training may be related to its non-mental health-specific nature. This is being tackled by trusts arranging for additional training. The lack of supervisor support suggests that there is a need to explore further the knowledge, skills and confidence of psychiatrists undertaking a nurse prescribing supervision role. Active resistance to implementation from psychiatrists seems relatively rare and may be tackled by trusts emphasising the potential benefits to both patients and staff by the introduction of NSP and by ensuring that early trials are well evaluated and publicised within trusts. Anecdotal evidence suggests that some resistance may arise from a misunderstanding as to the nature of NSP, with it being confused with independent nurse prescribing which takes place totally independently of a medical opinion.
It will be important for trusts to ensure that they have addressed local implementation issues prior to the commencement of training for mental health nurses as supplementary nurse prescribers.
|
|
|---|
This article has been cited by other articles:
![]() |
M.-L. Kwentoh and J. Reilly Non-medical prescribing: the story so far The Psychiatrist, January 1, 2009; 33(1): 4 - 7. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Tomar, T. Jakovljevic, and N. Brimblecombe Psychiatrists' and nurses' views of mental health nurse supplementary prescribing: a survey The Psychiatrist, October 1, 2008; 32(10): 364 - 365. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Tomar Supplementary prescribing by nurses The Psychiatrist, July 1, 2008; 32(7): 274 - 274. [Full Text] [PDF] |
||||
![]() |
G. Harborne and A. Jones Supplementary prescribing: a new way of working for psychiatrists and nurses The Psychiatrist, April 1, 2008; 32(4): 136 - 139. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||